Fresenius is a German healthcare group active across hospital care, clinical nutrition and infusion therapies, and medical products for critical and chronic care. Through its businesses it serves hospitals, clinics, and patients needing complex therapies and inpatient treatment. Scale in European hospital operations and specialty hospital products is a core differentiator versus pure-play pharma or device companies.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q4 2024 | 5,630 | — | 240 | — |
| Q1 2025 | 5,706 | — | 229 | — |
| Q2 2025 | 5,650 | — | 330 | — |
| Q4 2025 | 6,156 | 9.3% | 361 | 50.4% |
| Q1 2026 | 5,818 | 2% | 435 | 90% |
| Q2 2026 | 5,945 | 5.2% | 382 | 15.8% |
All markets — KeepWinning global stock screener
Other companies on DAX: MTU Aero Engines (MTX), Beiersdorf (BEI), Vonovia (VNA), Continental (CON), Symrise (SY1), GEA Group (G1A)